AU2023901403A0 - Anti-SARS-CoV-2 antibodies and uses thereof III - Google Patents

Anti-SARS-CoV-2 antibodies and uses thereof III

Info

Publication number
AU2023901403A0
AU2023901403A0 AU2023901403A AU2023901403A AU2023901403A0 AU 2023901403 A0 AU2023901403 A0 AU 2023901403A0 AU 2023901403 A AU2023901403 A AU 2023901403A AU 2023901403 A AU2023901403 A AU 2023901403A AU 2023901403 A0 AU2023901403 A0 AU 2023901403A0
Authority
AU
Australia
Prior art keywords
cov
sars
antibodies
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2023901403A
Inventor
Chi ONG
Steven ROCKMAN
Kirsten VANDENBERG
Erin VERITY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seqirus Pty Ltd
Original Assignee
Seqirus Pty Ltd
Filing date
Publication date
Application filed by Seqirus Pty Ltd filed Critical Seqirus Pty Ltd
Publication of AU2023901403A0 publication Critical patent/AU2023901403A0/en
Pending legal-status Critical Current

Links

AU2023901403A 2023-05-09 Anti-SARS-CoV-2 antibodies and uses thereof III Pending AU2023901403A0 (en)

Publications (1)

Publication Number Publication Date
AU2023901403A0 true AU2023901403A0 (en) 2023-05-25

Family

ID=

Similar Documents

Publication Publication Date Title
EP4010378A4 (en) Anti-ccr8 monoclonal antibodies and uses thereof
EP3918323A4 (en) Anti-gal3 antibodies and uses thereof
EP4151652A4 (en) Anti-cd73 antibody and use thereof
EP4126938A4 (en) Antibodies binding siglec15 and uses thereof
EP4095160A4 (en) Anti-st2 antibody and application thereof
EP4039708A4 (en) Anti-cll1 antibody and application thereof
EP3962954A4 (en) Anti-galectin-9 antibodies and uses thereof
EP4159763A4 (en) Anti-cd73 antibody and use thereof
EP4001308A4 (en) Anti-tigit antibodies and application thereof
EP4095157A4 (en) Anti-angptl3 antibody and use thereof
EP4132974A4 (en) Anti-cd98 antibodies and uses thereof
TWI799855B (en) NOVEL MONOCLONAL ANTIBODIES AGAINST SARS-CoV-2 AND USES THEREOF
EP4234580A4 (en) Nkg2a-targeting antibody and use thereof
AU2022298850A1 (en) Anti-ccr8 antibodies and uses thereof
EP3947462A4 (en) Anti-galectin-9 antibodies and uses thereof
EP4153313A4 (en) Anti-sars-cov-2 antibodies and uses thereof
EP4274851A4 (en) Anti-gprc5d monoclonal antibodies and uses thereof
EP4169950A4 (en) Anti-lilrb1 antibody and uses thereof
EP4079758A4 (en) Semg2 antibody and use thereof
AU2023901403A0 (en) Anti-SARS-CoV-2 antibodies and uses thereof III
TW202428607A (en) Anti-pdl1 antibodies and uses thereof
AU2023901399A0 (en) Anti-SARS-CoV-2 antibodies and uses thereof
AU2023901335A0 (en) Anti-NPY-Y1 antibodies and uses thereof
AU2023218343A1 (en) Anti-il13ra2 antibodies and uses thereof
AU2022901165A0 (en) Anti-NPY-Y1 antibodies and uses thereof